ABSTRACT OBJECTIVE: The aim of the study was to explore the variations in body mass index (BMI) trajectories during the 20 years before diagnosis of type 2 diabetes mellitus (T2DM) over four decades between 1968 and 2007.
T he type 2 diabetes mellitus (T2DM) epidemic, along with the rapid increase in the epidemic of overweight and obesity, has become a major public health concern in Canada, 1 and globally. 2, 3 The global and societal burden of these epidemics is increasingly implicated in a reduction in life expectancy, increased health care costs and increased poor health outcomes. [4] [5] [6] Reports indicate that the number of people given a diagnosis of T2DM is increasing, perhaps because of factors such as population aging, and increasing rates of obesity and sedentary lifestyle. 4 Many ecological studies have described a trend of obesity in relation to an elevated risk of adverse health effects, 7, 8 including the risk of developing chronic diseases such as T2DM. [9] [10] [11] [12] Despite limitations in the use of reported body mass index (BMI) (the weight of a person relative to the square of the person's height) to measure obesity and determine the potential risk of adverse health effects, 13, 14 measured BMI is still useful and widely used for screening, counselling and disease management purposes. [15] [16] [17] A number of prospective epidemiological studies have used BMI to support the association between measures of obesity and T2DM. 18, 19 A recent study demonstrated that higher BMI is strongly and independently associated with the risk of a diagnosis of T2DM. 10 However, such cross-sectional studies have limitations in investigating the effect of change in BMI in individuals over time, which is key to establishing the trend of obesity and associated elevated risk of T2DM at a population level. The adult life course of BMI trajectories in men over time is largely unknown and has mostly been extrapolated from cross-sectional studies. 20 Furthermore, there is a lack of concrete evidence as to whether the two chronic disease epidemics of obesity and T2DM are continuing in parallel over time. As well, there is no research discriminating between age, period and cohort effect in the change of BMI over time before the diagnosis of T2DM. The purpose of this study was to characterize individual trajectories of BMI during a 20-year window before the diagnosis of T2DM among Canadian men and to compare these trajectories by decade for the period 1968-2007. We hypothesized that there would be a significant variation in the 20-year BMI trajectories before diagnosis over the four decades.
This study is important in highlighting whether obesity patterns among those with a diagnosis of T2DM have been changing in recent decades and will inform policy regarding public health practice in the management of people at risk of T2DM.
METHODS

Data source and study subjects
The Manitoba Follow-Up Study (MFUS), housed at the University of Manitoba, is the largest and longest running longitudinal study in Canada. Information from routine medical examinations, including measurements of body weight, have been collected from annual contact with a cohort of 3,983 healthy young men since July 1948. Diagnosis of T2DM was reported by each man's physician and was not self-reported by study subjects. Body weight was routinely measured in physicians' offices. Height was measured and reported by a physician at the baseline examination, and that height was used for BMI evaluation over time. An overview of the MFUS and its examination protocol has recently been described in detail. [21] [22] [23] The adult male study participants selected for this analysis had each been given a diagnosis of T2DM between 1968 and 2007. All weight measurements on file during the 20 years before diagnosis were extracted for each man. Individuals whose condition was diagnosed before 1968 were excluded from the analysis because of lack of a previous 20-year recording of weight. In total, 437 adult men with 3,578 weight measurements met the criteria for this analysis. BMI was calculated as body weight divided by the square of height (kg/m 2 ).
Data analysis
Men were grouped by year of diagnosis of T2DM into one of four decades: 1968-1977, 1978-1987, 1988-1997 and 1998-2007 . A potential cohort effect on the variation in BMI trajectories over time before diagnosis was controlled for by the design of the study, in that the men within each decade of diagnosis of T2DM had a narrow range of year of birth. Analysis of variance (ANOVA) was used to assess differences in the mean BMI at diagnosis among decades. As the study design involved multiple measurements of BMI for each man, repeated measures analysis was used to examine the variation in BMI trajectories between decades of diagnosis of T2DM. A conditional multilevel growth model, with age at diagnosis as a covariate, was designed to examine the variation in the pattern of BMI trajectories over time among men given a diagnosis in four different decades. In the analysis, time was defined as the difference between the date of each BMI measurement and date of diagnosis of T2DM. The adequacy of the final trend model was assessed by including higher-order polynomial trend terms. The significance of the difference in maximized log-likelihood (or the likelihood ratio test statistic) was examined to determine whether it would be necessary to add linear and quadratic random slopes to the model. [24] [25] [26] Model fit comparisons were evaluated using the Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC). A goodness-of-fit statistic was used to compare across a series of models, and the unstructured maximum likelihood method, which yielded the smallest AIC and BIC values, was used to examine the change in the pattern of BMI trajectories over decades. 25 To yield a more easily interpretable intercept, 25 age at diagnosis was centred at its grand mean of 67.5 years. Because of the unbalanced nature of these longitudinal data, arising from a variable number and spacing of BMI measurements per man, the continuous variable "time prior to diagnosis" was centred at its mean (10.3 years) before higher-order polynomial terms were included. This not only helped to make the regression intercept interpretable but also alleviated potential problems associated with collinearity between the linear and higher-order terms of time.
26
A final random intercept and slope regression model, with random linear and quadratic time effects fitted to the data, was used to assess potential variation in the trend of BMI over time. A quadratic growth model was chosen to describe the fundamental structure of the change in the pattern of BMI trajectories during the 20 years before the diagnosis. In addition, the variance components of the linear and quadratic terms of time, the variances of curvature, as well as the covariance of the quadratic term with the linear term and their covariances with the initial status for both terms were added to the model. The deviance statistic was used to assess whether the associated random effects should be added to the model. Finally, the change point of the quadratic curve was determined by evaluating the first derivative to assess difference in the rate of change in BMI among decades. A level of significance for all tests was set at <0.05 and the analysis was conducted using SAS version 9.2. 27 The ongoing operation of MFUS receives annual ethical approval from the University of Manitoba Health Research Ethics Board.
RESULTS
Over the four decades between1968 and 2007, 437 men (11% of the 3,983 MFUS participants) were given a diagnosis of T2DM. Nearly 94% of these men were born in a 15-year period, 1910-1925. Understanding the trajectory of BMI over time before the diagnosis of T2DM The trajectory of BMI during the 20 years before the diagnosis of T2DM exhibits a quadratic polynomial trend within each decade of diagnosis. This trend is concave in shape over the time axis, indicating that the trend in BMI changed from an increase beginning 20 years before diagnosis to a decrease leading up to diagnosis. The effect of time in each decade can be obtained by adding the coefficient of the quadratic time term to the coefficient of the interaction between time and decade. Furthermore, the rate of change in BMI significantly decreased by 0.006 (p < 0.01) BMI units per unit time as age at diagnosis increased, suggesting that the rate of change in BMI was lower among men whose condition was diagnosed at an older rather than a comparatively young age.
Using fixed effect coefficients in Table 2 , the predicted BMI trajectory can be plotted as a quadratic polynomial function for each decade of diagnosis. As an illustrative example, decadespecific results using different ages at diagnosis are depicted by Figure 2 . In Figure 2 , panels B, C and D show subtle differences in patterns of BMI trajectories plotted at mean age 65, 67.5 (grand mean age at diagnosis) and 70 years respectively. It is also apparent that within all four decades, there are different intercepts during the 20 years before diagnosis, as well as different non-constant rates of change of mean BMI over time. The increasing trend in the mean BMI followed by a decreasing trend before the date of diagnosis varied by decade. The estimated peak BMI was found across decades at a time ranging from 2.9 to 12.4 years before the decline to diagnosis. Variation in the estimated instantaneous rate of change in mean BMI among men with a diagnosis in different decades also exists, with an 8.8% to 22.6% increase over the 10 years before diagnosis for an average man given a diagnosis in the two most recent decades as compared with in 1968-1977. Figure 2 also illustrates the significant effect of age at diagnosis on the change in the pattern of mean BMI over time, with relatively younger men having higher rates of change in the increase of BMI compared with older men. Age at diagnosis also affects the duration of the change in mean BMI from an Table 1 .
Characteristics of study subjects: Mean and standard deviations (SD) of body mass index (BMI)* by decade of diagnosis of type 2 diabetes mellitus (T2DM) increasing trend over time to a decreasing trend. For clarity, let us compare men given a diagnosis in the same decade, between 1988 and 1997, but at different ages, 67.5 ( Figure 2C ) and 70 ( Figure 2D ).
The time during which the trend of mean BMI changes from an increasing to a decreasing trend for men aged 67.5 and 70 years is estimated at 2.9 and 5.3 years prior to diagnosis respectively.
DISCUSSION
This study demonstrated that there has been significant variation in the trajectories of BMI prior to diagnosis of T2DM in men over the past four decades. This variation is characterized by both period and age at diagnosis effects. There has been a steady increase of BMI before diagnosis among men whose condition was diagnosed in recent decades. This significant increase in BMI in recent decades could be reflective of secular trends in society, in which, in general, the population is getting heavier, 28, 29 in
North America, the higher the BMI the higher the risk of T2DM diagnosis. 10 Not unlike many chronic diseases, T2DM has multiple causes, including genetics, ethnicity and a myriad other factors. Diagnosis of T2DM depends on the elevation of risk factors. 30 Individuals with more severe disease or those with multiple moderately elevated risk factors could be more prone to earlier diagnosis. If T2DM is diagnosed at a later stage (protopathic bias), the individual could have lost weight as a result of a hypercatabolic state. As the T2DM epidemic advanced in recent years, awareness increased. Clinical and public health practices such as screening have been put into place in recent decades and could have identified people at an earlier stage of T2DM before weight loss had begun. The variation in patterns of BMI trajectories among decades was also illustrated in terms of the duration of time during which the Figure 2 . Age-specific predicted patterns of BMI trajectories over the 20 years before diagnosis of T2DM by decade of diagnosis increasing trend in BMI persisted prior to declining before diagnosis: that time of increase was much longer for men whose condition was diagnosed in the most recent two decades. Physiologically, this may suggest that there is loss of weight prior to diagnosis. Other reasons could be the rapid onset of β-cell dysfunction once individuals reach the diagnostic threshold, which would then result in the hypercatabolic state. With regard to the first, the progress of T2DM could be related to hyperinsulinemia and insulin resistance when the person is obese; the pancreas produces more insulin, but this is insufficient or there is a deficiency in its action. Following this we could have a phase when the β-cells fail and the insulin levels are low when individuals start losing weight. The study also revealed that there was significant difference in the rate of change of mean BMI over time between decades. This perhaps reflects the possibility that T2DM manifestation in the early decades might be more advanced and possibly related to factors other than obesity. In addition, a number of changes in society over time, including diet, inactivity, transportation systems and a shift to a more industrialized workforce with less labour-intensive work, might also have contributed to the steady increase in rate of change in BMI in recent decades. On average, relatively younger men at diagnosis have a steeper rate of change in mean BMI compared with older men. Obesity is more prevalent among people after age 40 29, 31 but declines as they begin to lose muscle mass and experience slower metabolism and lower physical activity as they age. 32 This variation in rate of BMI change with age could potentially be attributed to the change in body fat composition and agedependent loss of height among older men. 33, 34 Our results should be interpreted in light of the study's limitations. First, despite evidence that there is loss of height with aging that affects BMI without weight change, 35 this study did not account for any potential loss of height with aging. All subjects in our analysis were given a diagnosis of T2DM, and hence our results must be interpreted as an investigation of trends of BMI trajectories over time before the onset of T2DM and not of trends over time in BMI in general. In addition, further research is needed to determine whether the variation in the duration of time that BMI persistently increased before the decline to diagnosis is related to the lag in time from obesity onset to the start of chronic inflammation, insulin resistance and subsequent diagnosis of T2DM. In summary, though we know that men in this study whose condition was diagnosed between 1998 and 2007 were older than those with a diagnosis in earlier decades, and age at diagnosis is found to inversely affect the changes in BMI over time, it is difficult to rule out that the decrease in the rate of change of BMI at diagnosis compared with 1988-1997 could be exclusively due to an age effect. Thus, as variations in the changes of patterns of BMI trajectories with aging across individuals could be ascribed to lifestyle, social and other biological factors, [36] [37] [38] a period effect could also play a significant role in the differential of BMI at diagnosis during the recent two decades. It is possible that the increase in BMI over time in those recent decades could be attributed to both an age effect and also to a period effect. This supports the suggestion that the rise of twin chronic epidemics of obesity and T2DM in the past few decades are related.
We suggest that any preventive strategies against T2DM informed by the pattern of BMI trajectories should be customized to take account of the potential age-period effect. Given the evidence that higher BMI is closely linked to an increased risk of a T2DM diagnosis, 10 our findings are consistent with higher BMI levels steadily increasing for much longer in recent decades among men with a diagnosis of T2DM. This is important for clinical and public health practice, such as targeted health promotion for adult men. As T2DM can develop in individuals without symptoms, consideration of patterns of BMI trajectories in intervention strategies might identify those at higher risk of T2DM. Therefore, clinicians should be aware of these trends and tailor health promotion to reflect their realities, reinforcing the need for men to adhere to weight management strategies, including physical activity and healthy eating. This will help to prevent or delay the onset of T2DM as well as reduce the risk of potential adverse consequences of the disease. As more people live longer, this co-existing problem will be magnified, and the health care system should adjust and be prepared for more obese patients with higher medical needs, as well as the potential increased costs associated with obesity and T2DM. CONCLUSION : Les trajectoires de l'IMC au cours des 20 années antérieures au DST2 variaient selon la décennie du diagnostic. L'augmentation de l'IMC persistait beaucoup plus longtemps chez les hommes relativement plus jeunes diagnostiqués au cours des décennies plus récentes. Les stratégies de prévention du DST2, éclairées par les trajectoires de l'IMC, devraient être individualisées pour tenir compte d'un éventuel effet selon l'âge et la période.
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